External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience ECTRIMS 2021
Roche and Genentech at

ECTRIMS 2021

October 13 - October 15
Virtual
ectrims-congress.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Highlights
Coming soon
06:00 PM
Duration 5mins Virtual
Long-term efficacy of satralizumab▼ in aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD): Results from the open-label extension periods of SAkuraSky and SAkuraStar
I. Kleiter, A. Traboulsee, J. Palace, T. Yamamura, K. Fujihara, A. Saiz, H-C. von Buedingen, D. Stokmaier, G. Klingelschmitt, J. Bennett
Neuroscience | Neuromyelitis Optica

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:45 PM
Duration 60mins Virtual
The evolving landscape in neuromyelitis optica spectrum disorder (NMOSD) management
Kleiter I, Fujihara K, Greenberg B
Neuroscience | Neuromyelitis Optica

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:33 PM
Duration 7mins Virtual
Sustained Reduction in 48-week Confirmed Disability Progression in Patients with PPMS Treated with Ocrelizumab▼ in the ORATORIO OLE: 8-year Follow-up
Wolinsky JS, Vermersch P, Hartung HP, Naismith RT, Airas L, Townsend B, Schneble HM, Overell J, Sauter A, Wang Q, Prajapati K, Kappos L
Neuroscience | Multiple Sclerosis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

Sign up or login to unlock the full suite of MEDICALLY features
2021 ECTRIMS Annual Congress In-Depth Report
Springer Healthcare
Open asset

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.